INSR and metabolic dysfunction-associated steatotic liver disease: Studies have shown that IL-6 could impede insulin receptor signaling, lead to IR, and aggravate NAFLD development by inhibiting the expression of IRS-1, GLUT4, and phosphatidylinositol 3-kinase (Park et al., 2010; Wided et al., 2014).